Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: Correlation with tumor progression and poor prognosis

Oncology

Volumn 76, Issue 6, 2009, Pages 387-397

  Shinozuka, Keiji ^a   Uzawa, Katsuhiro ^a,b   Fushimi, Kazuaki ^a   Yamano, Yukio ^a   Shiiba, Masashi ^a   Bukawa, Hiroki ^b   Yokoe, Hidetaka ^b   Tanzawa, Hideki ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Carcinoembryonic antigen related cell adhesion molecule 1; Immunohistochemistry; Microarray analysis; Oral squamous cell carcinoma; Pathway analysis; Real time quantitative reverse transcriptase polymerase chain reaction; Western blot

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD66 ANTIGENS; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; DEVICE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; WESTERN BLOTTING; AGED; BIOSYNTHESIS; DISEASE COURSE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; KERATINOCYTE; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; TUMOR CELL LINE;

AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS;

EID: 65449136397     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215580     Document Type: Article

References (46)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
3. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT: Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base Report. Head Neck 2002;24:165-180.
4. Weinberg MA, Estefan DJ: Assessing oral malignancies. Am Fam Physician 2002;65:1379-1384.
5. Okamoto M, NishimineM, Kishi M, Kirita T, Sugimura M, Nakamura M, Konishi N: Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med 2002;31:227-233.
6. Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB: Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004;26:984-994.
7. Ribeiro KC, Kowalski LP, Latorre MR: Impact of comorbidit y, symptoms, and patients' characteristics on the prognosis of oral carcinomas. Arch Otolaryngol Head Neck Surg 2000;126:1079-1085.
8. Sparano A, Weinstein G, Chalian A, Yodul M, Weber R: Multivariate predictors of occult neck metastasis in ea rly oral tongue ca n-cer. Otolaryngol Head Neck Surg 2004;131:472-476.
9. Califono J, vander Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-2492.
10. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
11. Marshall CJ: Tumor suppressor genes. Cell 1991;64:313-326.
12. Odani T, Ito D, Li MH, Kawamata A, Isobe T, Iwase M, Nagumo M: Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology. Int J Oncol 2006;28:619-624.
13. Tomioka H, Morita K, Hasegawa S, Omura K: Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med 2006;35:206-211.
14. Leethanakul C, Knezevic V, Patel V, Amornphimoltham P, Gillespie J, Shillitoe EJ, Emko P, Park MH, Emmert-Buck MR, Strausberg RL, Krizman DB, Gutkind JS;Head and Neck Cancer Genome Anatomy Project: Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray ana lysis. Oral Oncol 2003;39:248-258.
15. Koike H, Uzawa K, Nakashima D, Shimada K, Kato Y, Higo M, Kouzu Y, Endo Y, Kasamatsu A, Tanzawa H: Identification of differentially expressed proteins in oral squa-mous cell carcinoma using a global proteomic approach. Int J Oncol 2005;27:59-67.
16. Kouzu Y, Uzawa K, Koike H, Saito K, Nakashima D, Higo M, Endo Y, Kasamatsu A, Shiiba M, Bukawa H, Yokoe H, Tanzawa H: Overexpression of stathmin in oral squa-mous cell carcinoma: correlation with tumour progression and poor prognosis. Br J Cancer 2006;94:717-723.
17. Kasamatsu A, Uzawa K, Na kashima D, Koike H, Shiiba M, Bukawa H, Yokoe H, Tanzawa H: Galectin-9as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med 2005;16:269-273.
18. Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N, Tanzawa H: Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 2005;92:1915-1921.
19. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, Tanzawa H: Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 2003;82:607-611.
20. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC: Loss of KAI1expression in the progression of colorectal cancer. Cancer Res 1999;59:5724-5731.
21. Bamberger AM, Sudahl S, Löning T, Wagener C, Bamberger CM, Drakakis P, Coutifaris C, Makrigiannakis A: The adhesion molecule CEACAM1(CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast. Am J Pathol 2000;156:1165-1170.
22. Prall F, Nollau P, Neumaier M, Haubeck HD, Drzeniek Z, Helmchen U, Löning T, Wagener C: CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J Histochem Cytochem 1996;44:35-41.
23. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
24. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-395.
25. Volpert O, Luo W, Liu TJ, Estrera VT, Logothetis C, Lin SH: Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. J Biol Chem 2002;277:35696-35702.
26. Oliveira-Ferrer L, Tilki D, Ziegeler G, Hauschild J, Loges S, Irmak S, Kilic E, Huland H, Friedrich M, Ergün S: Dual role of carcinoembryonic antigen-related cell adhesion molecule 1in angiogenesis and invasion of human urinary bladder cancer. Cancer Res 2004;15:8932-8938.
27. Thompson JA, Grunert F, Zimmermann W: Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991;5:344-366.
28. Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F, Hammarström S, Holmes KV, Karlsson A, Kuroki M, Lin SH, Lucka L, Najjar SM, Neumaier M, Obrink B, Shively JE, Skubitz KM, Stanners CP, Thomas P, Thompson JA, Virji M, von Kleist S, Wagener C, Watt S, Zimmermann W: Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 1999;252:243-249.
29. Kuroki M, Arakawa F, Matsuo Y, Oikawa S, Nakazato H, Matsuoka Y: Three novel molecular forms of biliary glycoprotein deduced from cDNA clones from a human leukocyte library. Biochem Biophys Res Commu n 1991;176:578-585.
30. Barnett TR, Drake L, Pickle W: Human biliary glycoprotein gene: characterization of a family of novel alternatively spliced RNAs and their expressed proteins. Mol Cell Biol 1993;13:1273-1282.
31. Nakajima A, Iijima H, Neurath MF, Nagaishi T, Nieuwenhuis EE, Raychowdhury R, Glick-man J, Blau DM, Russell S, Holmes K V, Blumberg RS: Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1regulates mouse T lymphocyte function. J Immunol 2002;168:1028-1035.
32. Chen D, Iijima H, Nagaishi T, Nakajima A, Russell S, Raychowdhury R, Morales V, Rudd CE, Utku N, Blumberg RS: Carcinoembryonic antigen-related cellular adhesion molecule 1isoforms alternatively inhibit and costimulate human T cell function. J Immunol 2004;172:3535-3543.
33. Huang J, Simpson JF, Glackin C, Riethorf L, Wagener C, Shively JE: Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells. Anticancer Res 1998;18:3203-3212.
34. Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C: Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci USA 1993;90:10744-10748.
35. Bamberger AM, Riethdorf L, Nollau P, Nau-mann M, Erdmann I, Götze J, Brümmer J, Schulte HM, Wagener C, Löning T: Dysregu-lated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer. Am J Pathol 1998;152:1401-1406.
36. Busch C, Hanssen TA, Wagener C, OBrink B: Down-regulation of CEACAM1in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3to 4transition. Hum Pathol 2002;33:290-298.
37. Luo W, Tapolsky M, Earley K, Wood CG, Wilson DR, Logothetis CJ, Lin SH: Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther 1999;6:313-321.
38. Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT: Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res 1995;55:1215-1220.
39. Kleinerman DI, Dinney CP, Zhang WW, Lin SH, Van NT, Hsieh JT: Suppression of human bladder cancer growth by increased expression of C-CAM1gene in an orthotopic model. Cancer Res 1996;56:3431-3435.
40. Borscheri N, Roessner A, Rocken C: Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am J Surg Pathol 2001;25:1297-1303.
41. Cruz PV, Wakai T, Shirai Y, Yokoyama N, Hatakeyama K: Loss of carcinoembryonic antigen-related adhesion molecule 1is an adverse prognostic factor in hepatocellularcarcinoma. Cancer 2005;104:354-360.
42. Kunath T, Ordonez-Garcia C, Turbide C, Beauchemin N: Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene 1995;11:2375-2382.
43. Liu W, Wei W, Winer D, Bamberger AM, Bamberger C, Wagener C, Ezzat S, Asa SL: CEACAM1impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene 2007;26:2747-2758.
44. Bockmühl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, Petersen I: Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 1997;57:5213-5216.
45. Bockmühl U, Petersen I: DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma. Virchows Arch 2002;441:541-550.
46. Bockmühl U, Schlüns K, Schmidt S, Matthias S, Petersen I: Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2002;33:29-35.